Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Jan 17 2023

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 17, 2023, titled "Heart failure treatment becomes more affordable with Glenmark launching theSacubitril + Valsartan tablets in India".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases